Background—In case series, mitral regurgitation (MR) increased the risk of death after
myocardial infarction (MI), yet the prevalence of MR, its incremental prognostic value over …

Objectives: The aim of this study was to determine the prognostic value of right ventricular
(RV) function in patients after a myocardial infarction (MI). Background: Right ventricular …

2013 ACCF/ACR/ASE/ASNC/SCCT/SCMR Appropriate Utilization of Cardiovascular
Imaging in Heart Failure: A Joint Report of the American College of Radiology …

Aims The study assessed 4‐year outcomes of intramyocardial injections of autologous bone
marrow‐derived mesenchymal stromal cells (MSCs) in patients with ischaemic heart failure …

dysfunction, decreasing the leaflet closing force, 22 as opposed to PM wall tethering.
Conceivably, however, the acute PM wall displacement in that study was insufficient to …

Following myocardial infarction (MI), circulating blood monocytes respond to chemotactic
factors, migrate into the infarcted myocardium, and differentiate into macrophages. At the …

Background: Patients with left ventricular (LV) systolic dysfunction after myocardial infarction
are at a high risk of developing heart failure. The addition of neprilysin inhibition to renin …

Background: Guidelines recommend surgery for patients with severe ischemic mitral
regurgitation (MR). Nonrandomized studies suggest that subvalvular repair is associated …

Rationale: Despite 4 decades of intense effort and substantial financial investment, the
cardioprotection field has failed to deliver a single drug that effectively reduces myocardial …

Background—Angiotensin-converting enzyme (ACE) inhibitors have been shown to
attenuate left ventricular (LV) enlargement in association with reducing mortality after …